We like to keep our readers up to date on complex regulatory issues, the latest industry trends and updated guidelines to help you to solve a problem or make an informed decision.
Latest Blog posts
blog
How can you take advantage of China’s accelerated regulatory pathways for your product development?
Global drug innovation in the East has significantly increased in recent years. China is one of the major players and…
blog
The EU Regulatory Framework for Microbiota Transplants: An Industry Perspective
The current European regulatory framework for Blood Tissue and Cells is being replaced by a new Regulation, which includes a…
blog
Key Points in the CTR Transition of Clinical Trials
Are you an innovator with a product undergoing clinical trial? This article covers all you need to know about the…
blog
Critical Materials considerations for Cell and Gene therapy product development – Part 2
In Part 1 of this blog, we covered the definitions of Starting Materials, Raw Materials, and Ancillary Materials. In Part…
blog
Critical Materials considerations for Cell and Gene therapy product development – Part 1
Raw and starting materials are an essential part of cell-based and gene therapy products (CGT). Frequently, the development of Cell…
blog
FDA Meeting Series: How, When and What – EOP Meetings
End-of-phase (EOP) meetings occur when development has reached the end of a particular phase and is ready to move to…
blog
FDA Meeting Series: How, When and What – pre-IND Meetings
pre-IND Meetings What: pre-Investigational New Drug application (pre-IND) meetings are formal PDUFA Type B meetings held between a sponsor…
blog
FDA Meeting Series: How, When and What – General Introduction
The Food and Drug Administration (FDA) offers sponsors many opportunities for interaction and guidance during the course of drug development…
Resources 